Ibex Investors’s Prestige Consumer Healthcare PBH Stock Holding History

Ibex Investors’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-23,612	Closed	-$748	–	94
2019 Q2	$748	Sell	23,612 -2,303	-9%	-$68.4K	0.06%	42
2019 Q1	$775K	Sell	25,915 -1,050	-4%	-$30.1K	0.07%	37
2018 Q4	$833K	Sell	26,965 -7,013	-21%	-$256K	0.14%	36
2018 Q3	$1.29M	Buy	+33,978	New	+$1.29M	0.71%	41

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Ibex Investors's PBH Position: Q3 2019 in Review

Ibex Investors sold out of Prestige Consumer Healthcare (PBH) in Q3 2019, closing a stake of 23,612 shares — an estimated $748 sold.

Ibex Investors first reported a position in PBH in Q3 2018 and held it in 4 quarters. The position peaked at $1.29M in Q3 2018. 230 funds tracked by Wall St. Rank hold PBH as of Q3 2019.

Ibex Investors reported no remaining Prestige Consumer Healthcare position as of Q3 2019 after selling out during the quarter.
Ibex Investors sold 23,612 Prestige Consumer Healthcare shares in Q3 2019, an estimated $748.
Ibex Investors first reported a position in Prestige Consumer Healthcare in Q3 2018 and held it in 4 quarters.
Ibex Investors's Prestige Consumer Healthcare position peaked at $1.29M in Q3 2018.
230 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2019.

Based on Ibex Investors's 13F filing for Q3 2019, filed 1 Nov 2019.